Skip to main content

Sagent Pharmaceuticals Inc (NASDAQ:SGNT) Investor Investigation Over Potetnail Wrongdoing In Acquisition Announced

  • If you purchased shares of Sagent Pharmaceuticals Inc (NASDAQ:SGNT) and currently hold any of those NASDAQ:SGNT shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

July 15 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Sagent Pharmaceuticals Inc (NASDAQ:SGNT), was announced concerning whether the takeover of Sagent Pharmaceuticals Inc by Nichi-Iko Pharmaceutical Co., Ltd is unfair to NASDAQ:SGNT stockholders. The investigation by a law firm concerns whether certain officers and directors of...

You must register (for free) or login to view the entire investigation.